Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,Whats new CLL KC

    New case-based chronic lymphocytic leukaemia
    CME module

    A new CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been
    added to the CLL Knowledge Centre on epgonline.org. Read case studies and improve
    your knowledge of CLL by answering quiz questions based on a variety of scenarios. This
    module has been EACCME-accredited and is worth 1 European CME credit. There is no cost
    to complete this educational activity.

  • ,Hypogonadism Relaunch Whats New

    Launch of updated Hypogonadism Knowledge Centre

    Our Hypogonadism Knowledge Centre contains important disease awareness
    information to support healthcare professionals in the current best practice
    treatment and management of male hypogonadism and is available to access free of
    charge. Sections cover epidemiology, pathophysiology, signs and symptoms, treatment
    options, as well as useful resources and a regularly updated publications digest.

    G.MKT.GM.MH.01.2016.0364

  • ,

    New Type 2 Diabetes CME now available

    A new CME activity ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in
    Combination with Insulin’ has been added to the Type 2 Diabetes Learning Zone.
    Complete the five modules to enhance your understanding of the combination
    therapies available for treating type 2 diabetes.

  • ,COPD whats new ATS 2015

    ATS 2015 symposium materials added to
    COPD Knowledge Centre

    Speaker slides and a video from the Novartis-sponsored symposium ‘Are we gaining the
    maximum benefit from bronchodilators in COPD?’ have been added to the COPD Knowledge
    Centre. The session was held at the American Thoracic Society (ATS) conference 2015 to
    highlight the fundamental role of bronchodilators in COPD management, and presented
    key drug data including efficacy and safety of some of the latest COPD therapies.

  • ,Whats New CSU

    Updates to Chronic Spontaneous Urticaria
    Knowledge Centre

    Video presentations of faculty experts speaking at the 23rd World Congress of
    Dermatology (WCD) 2015 have been added to the Chronic Spontaneous Urticaria (CSU)
    Knowledge Centre. Topics discussed include diagnosis, burden and an overall clinical
    picture of urticaria.

Latest News

FDA advisory committee supports sNDA for Brintellix (vortioxetine) in major depressive disorder- Takeda/Lundbeck

05-Feb-2016

Takeda Pharmaceutical and Lundbeck have announced that the FDA's Psychopharmacologic Drugs Advisory Committee (PDAC) voted 8 to 2 that the companies presented substantial evidence to support the effectiveness of Brintellix (vortioxetine) for ...

FDA approves sNDA for Emend (fosaprepitant dimeglumine) in combination with other antiemetic medicines for prevention of delayed nausea and vomiting- Merck Inc

05-Feb-2016

Merck has announced that the FDA has approved a supplemental new drug application (sNDA) for single-dose Emend (fosaprepitant dimeglumine) for injection, in combination with other antiemetic medicines, for the prevention of delayed nausea and ...

Federal appeals court rules patents for Oxycontin are invalid.- Purdue Pharma

04-Feb-2016

A federal appeals court ruled that four patents related to OxyContin are invalid. Purdue had sued Teva, Amneal Pharmaceuticals, Epic Pharma and a U.S. arm of Mylan NV after they sought approval from the FDA to make generic OxyContin. The ruling by ...

European Commission approves Tagrisso to treat metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive NSCLC- AstraZeneca

04-Feb-2016

AstraZenea announced that the European Commission has approved Tagrisso (AZD9291, osimertinib) 80mg once-daily tablets for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M ...

FDA issues complete response letter for MCNA (urocidin, or Mycobacterium phlei Cell Wall-nucleic acid complex)) in bladder cancer- Telesta

04-Feb-2016

The FDA has issued a Complete Response Letter to Telesta's Biologics License Application for MCNA (Urocidin) in bladder cancer. In this letter, the FDA communicated that an additional Phase III clinical trial for MCNA would be necessary to adequately ...

Flulaval Quadrivalent (Influenza Vaccine) filed with FDA for expanded indication- GlaxoSmithKline

04-Feb-2016

GlaxoSmithKline has announced the submission of a supplemental Biologics License Application (sBLA) to the FDA for Flulaval Quadrivalent (Influenza Vaccine). This vaccine is currently approved for active immunisation against influenza A subtype ...

NICE recommends TNF-alpha inhibitors for ankylosing spondylitis

04-Feb-2016

NICE recommends Humira (adalimumab), from Abbvie, Cimzia (certolizumab pegol), from UCB, Enbrel (etanercept), from Pfizer, Simponi (golimumab), from Merck Inc and Remicade (infliximab), from Merck Inc, within their marketing authorisations, as ...

Recent Updates

Drugs

Clinical Guidelines

Care of dying adults in the last days of life

Intravenous fluid therapy in children and young people in hospital

Type 2 diabetes: The management of type 2 diabetes

Children’s attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care

Medical Journals

Psoriasis

Imatinib: a breakthrough of targeted therapy in cancer.

Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?

Prognostic Impact of IL-6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages

News

News

News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors